LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
99269-3 | Clonazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Clonazolam [Mass/volume] in Urine by Confirmatory method | Clonazolam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99270-1 | 8-Aminoclonazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | 8-Aminoclonazolam [Mass/volume] in Urine by Confirmatory method | 8-Aminoclonazolam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99271-9 | Flualprazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Flualprazolam [Mass/volume] in Urine by Confirmatory method | Flualprazolam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99272-7 | Alpha-hydroxy flualprazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method | A-OH flualprazolam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99273-5 | Meclonazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Meclonazepam [Mass/volume] in Urine by Confirmatory method | Meclonazepam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99274-3 | Flubromazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Flubromazepam [Mass/volume] in Urine by Confirmatory method | Flubromazepam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
9927-5 | Q wave depth.lead AVR | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead AVR | Q wave Dpth L-AVR | null | ACTIVE | 1.0i | 2.48 |
99275-0 | Phenazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Phenazepam [Mass/volume] in Urine by Confirmatory method | Phenazepam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99276-8 | 3-Hydroxyphenazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | 3-Hydroxyphenazepam [Mass/volume] in Urine by Confirmatory method | 3-OH-phenazepam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99277-6 | Pyrazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Pyrazolam [Mass/volume] in Urine by Confirmatory method | Pyrazolam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99278-4 | Flubromazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Flubromazolam [Mass/volume] in Urine by Confirmatory method | Flubromazolam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
99279-2 | Alpha-hydroxy flubromazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Alpha-hydroxy flubromazolam [Mass/volume] in Urine by Confirmatory method | A-OH flubromazolam Ur Cfm-mCnc | null | ACTIVE | 2.72 | 2.72 |
992-8 | D little o super little a Ab | PrThr | Pt | Ser/Plas^Donor | Ord | null | BLDBK | 1 | Do sup(a) Ab [Presence] in Serum or Plasma from Donor | Do sup(a) Ab SerPl Donr Ql | null | ACTIVE | 1.0 | 2.56 |
99280-0 | Cefiderocol | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Cefiderocol [Susceptibility] | Cefiderocol Susc Islt | null | ACTIVE | 2.72 | 2.72 |
99281-8 | Lefamulin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Lefamulin [Susceptibility] | Lefamulin Susc Islt | null | ACTIVE | 2.72 | 2.72 |
99282-6 | FDA-initiated compliance action drug registration and listing inactivation - animal drug | - | - | ^FDA product label | Nar | null | DOC.REF | 2 | FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug | FDA animal drug+list inactivation | null | ACTIVE | 2.72 | 2.72 |
9928-3 | Q wave depth.lead I | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead I | Q wave Dpth L-I | null | ACTIVE | 1.0i | 2.48 |
99283-4 | Tegner activity scale panel | - | Pt | ^Patient | - | Tegner | PANEL.SURVEY.GNHLTH | 4 | Tegner Activity Scale panel [Tegner] | null | null | ACTIVE | 2.72 | 2.72 |
99284-2 | Activity level before injury | Find | Pt | ^Patient | Nom | null | SURVEY.GNHLTH | 4 | Activity level before injury | null | null | ACTIVE | 2.72 | 2.72 |
99285-9 | Current activity level | Find | Pt | ^Patient | Nom | null | SURVEY.GNHLTH | 4 | Current activity level | null | null | ACTIVE | 2.72 | 2.72 |
99286-7 | Provision of current reconciled medication list to subsequent provider at transfer | Find | Pt | ^Patient | Ord | CMS Assessment | SURVEY.CMS | 4 | Provision of current reconciled medication list to subsequent provider at transfer [CMS Assessment] | null | null | ACTIVE | 2.72 | 2.72 |
99287-5 | Checklist of nonverbal pain indicators panel | - | Pt | ^Patient | - | CNPI | PANEL.SURVEY.CNPI | 4 | Checklist of nonverbal pain indicators panel [CNPI] | null | Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission | ACTIVE | 2.72 | 2.72 |
99288-3 | Checklist of nonverbal pain indicators with movement panel | - | Pt | ^Patient | - | CNPI | PANEL.SURVEY.CNPI | 4 | Checklist of nonverbal pain indicators with movement panel [CNPI] | null | Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission | ACTIVE | 2.72 | 2.72 |
99289-1 | Nonverbal vocal complaints during movement | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Nonverbal vocal complaints during movement | null | null | ACTIVE | 2.72 | 2.72 |
99290-9 | Facial grimaces or winces during movement | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Facial grimaces or winces during movement | null | null | ACTIVE | 2.72 | 2.72 |
9929-1 | Q wave depth.lead II | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead II | Q wave Dpth L-II | null | ACTIVE | 1.0i | 2.48 |
99291-7 | Bracing during movement | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Bracing during movement | null | null | ACTIVE | 2.72 | 2.72 |
99292-5 | Rubbing during movement | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Rubbing during movement | null | null | ACTIVE | 2.72 | 2.72 |
99293-3 | Restlessness during movement | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Restlessness during movement | null | null | ACTIVE | 2.72 | 2.72 |
99294-1 | Verbal complaints during movement | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Verbal complaints during movement | null | null | ACTIVE | 2.72 | 2.72 |
99295-8 | With movement score | Score | Pt | ^Patient | Qn | CNPI | SURVEY.CNPI | 4 | With movement score [CNPI] | null | Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission | ACTIVE | 2.72 | 2.72 |
99296-6 | Checklist of nonverbal pain indicators at rest panel | - | Pt | ^Patient | - | CNPI | PANEL.SURVEY.CNPI | 4 | Checklist of nonverbal pain indicators at rest panel [CNPI] | null | Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission | ACTIVE | 2.72 | 2.72 |
99297-4 | Nonverbal vocal complaints while at rest | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Nonverbal vocal complaints while at rest | null | null | ACTIVE | 2.72 | 2.72 |
99298-2 | Facial grimaces or winces while at rest | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Facial grimaces or winces while at rest | null | null | ACTIVE | 2.72 | 2.72 |
99299-0 | Bracing while at rest | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Bracing while at rest | null | null | ACTIVE | 2.72 | 2.72 |
99300-6 | Restlessness while at rest | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Restlessness while at rest | null | null | ACTIVE | 2.72 | 2.72 |
99301-4 | Rubbing while at rest | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Rubbing while at rest | null | null | ACTIVE | 2.72 | 2.72 |
99302-2 | Verbal complaints while at rest | Find | Pt | ^Patient | Ord | null | SURVEY.CNPI | 4 | Verbal complaints while at rest | null | null | ACTIVE | 2.72 | 2.72 |
99303-0 | At rest score | Score | Pt | ^Patient | Qn | CNPI | SURVEY.CNPI | 4 | At rest score [CNPI] | null | Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission | ACTIVE | 2.72 | 2.72 |
99304-8 | Total score | Score | Pt | ^Patient | Qn | CNPI | SURVEY.CNPI | 4 | Total score [CNPI] | null | Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission | ACTIVE | 2.72 | 2.72 |
99305-5 | Checklist of nonverbal pain indicators assessment | Imp | Pt | ^Patient | Nom | CNPI | SURVEY.CNPI | 4 | Checklist of nonverbal pain indicators assessment [CNPI] | null | Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission | ACTIVE | 2.72 | 2.72 |
99306-3 | Choriogonadotropin.beta subunit heterophile Ab interference panel | - | Pt | Ser | - | null | PANEL.CHEM | 1 | Choriogonadotropin.beta subunit heterophile Ab interference panel - Serum | B-HCG heterph Ab intrf Pnl Ser | null | ACTIVE | 2.72 | 2.72 |
99307-1 | Choriogonadotropin.beta subunit heterophile Ab interference | PrThr | Pt | Ser | Ord | null | CHEM | 1 | Choriogonadotropin.beta subunit heterophile Ab interference [Presence] in Serum | B-HCG heterph Ab intrf Ser Ql | null | ACTIVE | 2.72 | 2.72 |
99308-9 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) | PrThr | Pt | WBC | Ord | IB | CHEM | 1 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot | AAG CRIM WBC Ql IB | null | ACTIVE | 2.72 | 2.72 |
9930-9 | Q wave depth.lead III | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead III | Q wave Dpth L-III | null | ACTIVE | 1.0i | 2.48 |
99309-7 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) | PrThr | Pt | Tissue | Ord | IB | CHEM | 1 | Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot | AAG CRIM tiss Ql IB | null | ACTIVE | 2.72 | 2.72 |
99310-5 | Total score^^adjusted for age | Score | Pt | ^Patient | Qn | null | CLIN.RISK | 2 | Total score age adjusted | Total score age-adj | null | ACTIVE | 2.72 | 2.72 |
99311-3 | Seizure onset | Type | Pt | ^Patient | Nom | null | H&P.HX | 2 | Seizure onset | Seizure onset | null | ACTIVE | 2.72 | 2.72 |
99312-1 | Seizure frequency | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Seizure frequency | Seizure frequency | null | ACTIVE | 2.72 | 2.72 |
99313-9 | Time since last seizure | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Time since last seizure | Time since last seizure | null | ACTIVE | 2.72 | 2.72 |
99314-7 | SARS coronavirus 2 RdRp gene mutation detected | Prid | Pt | XXX | Nom | Molgen | MICRO | 1 | SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method | SARS-CoV-2 RdRp mut Spec | null | ACTIVE | 2.72 | 2.72 |
99315-4 | OASIS E - Intervention synopsis - DC, TRN | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | OASIS E - Intervention synopsis - DC, TRN [CMS Assessment] | null | null | ACTIVE | 2.72 | 2.72 |
9931-7 | Q wave depth.lead V1 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead V1 | Q wave Dpth L-V1 | null | ACTIVE | 1.0i | 2.48 |
9932-5 | Q wave depth.lead V2 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead V2 | Q wave Dpth L-V2 | null | ACTIVE | 1.0i | 2.48 |
9933-3 | Q wave depth.lead V3 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead V3 | Q wave Dpth L-V3 | null | ACTIVE | 1.0i | 2.48 |
9934-1 | Q wave depth.lead V4 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead V4 | Q wave Dpth L-V4 | null | ACTIVE | 1.0i | 2.48 |
99342-8 | Days since symptom started | Find | Pt | ^Patient | Ord | null | SURVEY.COVID | 4 | Days since symptom started | null | null | ACTIVE | 2.72 | 2.72 |
99343-6 | Days since symptom finished | Find | Pt | ^Patient | Ord | null | SURVEY.COVID | 4 | Days since symptom finished | null | null | ACTIVE | 2.72 | 2.72 |
99344-4 | Sought medical attention for symptoms | Find | RptPeriod | ^Patient | Nom | null | SURVEY.GNHLTH | 4 | Sought medical attention for symptoms | null | null | ACTIVE | 2.72 | 2.72 |
99345-1 | Type of medical attention accessed | Type | RptPeriod | ^Patient | Nom | null | SURVEY.GNHLTH | 4 | Type of medical attention accessed | null | null | ACTIVE | 2.72 | 2.72 |
99346-9 | Temperature taken | Find | RptPeriod | ^Patient | Ord | null | H&P.HX | 2 | Temperature taken Reporting Period | Temperature taken RptPeriod | null | ACTIVE | 2.72 | 2.72 |
99347-7 | Body temperature.max | Temp | RptPeriod | ^Patient | Qn | null | H&P.HX | 2 | Maximum body temperature Reporting Period | Body temp.max RptPeriod | null | ACTIVE | 2.72 | 2.72 |
99348-5 | Close contact with COVID-19 in last 2W | Find | 2W | ^Patient | Nom | null | SURVEY.COVID | 4 | Close contact with COVID-19 in last 2W | null | null | ACTIVE | 2.72 | 2.72 |
99349-3 | Has or had COVID-19 | Hx | Pt | ^Patient | Ord | null | SURVEY.COVID | 4 | Has or had COVID-19 | null | null | ACTIVE | 2.72 | 2.72 |
99350-1 | Date of first infection onset | Date | Pt | ^Patient | Nom | null | SURVEY.COVID | 4 | Date of first infection onset | null | null | ACTIVE | 2.72 | 2.72 |
99351-9 | Informed of being at severe risk from COVID-19 due to an underlying health condition | Find | Pt | ^Patient | Ord | null | SURVEY.COVID | 4 | Informed of being at severe risk from COVID-19 due to an underlying health condition | null | null | ACTIVE | 2.72 | 2.72 |
99352-7 | Has health problems that require activity limits | Find | Pt | ^Patient | Ord | null | SURVEY.GNHLTH | 4 | Has health problems that require activity limits | null | null | ACTIVE | 2.72 | 2.72 |
99353-5 | Has health problems that require staying at home | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Has health problems that require staying at home | Health prob require stay home | null | ACTIVE | 2.72 | 2.72 |
99354-3 | Mobility device or aid is regularly used | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Mobility device or aid is regularly used | Mobility device reg used | null | ACTIVE | 2.72 | 2.72 |
99355-0 | Takes routine medication | Find | Pt | ^Patient | Nom | null | H&P.HX | 2 | Takes routine medication | Takes routine med | null | ACTIVE | 2.72 | 2.72 |
99356-8 | Influenza virus vaccination received in last 12Mo | Find | 12Mo | ^Patient | Ord | null | H&P.HX | 2 | Influenza virus vaccination received in last 12 months | Flu vacc last 12Mo | null | ACTIVE | 2.72 | 2.72 |
99357-6 | COVID-19 health questions panel | - | Pt | ^Patient | - | null | PANEL.SURVEY.COVID | 4 | COVID-19 health questions panel | null | null | ACTIVE | 2.72 | 2.72 |
9935-8 | Q wave depth.lead V5 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead V5 | Q wave Dpth L-V5 | null | ACTIVE | 1.0i | 2.48 |
99359-2 | Person who performed clinical measurement | Type | Pt | ^Patient | Nom | null | H&P.HX | 2 | Person who performed clinical measurement | Clinical measurement by | null | ACTIVE | 2.72 | 2.72 |
993-6 | D little o super little a Ab | PrThr | Pt | Ser/Plas | Ord | null | BLDBK | 1 | Do sup(a) Ab [Presence] in Serum or Plasma | Do sup(a) Ab SerPl Ql | null | ACTIVE | 1.0 | 2.73 |
99360-0 | Bovine serum albumin Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Bovine serum albumin (BSA) IgG Ab [Mass/volume] in Serum | BSA IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99361-8 | Horse hair+Horse dander Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Horse hair+Horse dander IgG Ab [Mass/volume] in Serum | Horse Hair+Dander IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99362-6 | Euroglyphus maynei Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Euroglyphus maynei IgG Ab [Mass/volume] in Serum | E maynei IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99363-4 | Triticum spelta Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Spelt IgG Ab [Mass/volume] in Serum | Spelt IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99364-2 | Ovalbumin Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Ovalbumin IgG Ab [Mass/volume] in Serum | Ovalb IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99365-9 | Sheep milk Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Sheep milk IgG Ab [Mass/volume] in Serum | Sheep Milk IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
9936-6 | Q wave depth.lead V6 | Elpot | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave depth in lead V6 | Q wave Dpth L-V6 | null | ACTIVE | 1.0i | 2.48 |
99366-7 | Chicken meat Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Chicken meat IgG Ab [Mass/volume] in Serum | Chicken Meat IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99367-5 | Theobroma cacao Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Cocoa IgG Ab [Mass/volume] in Serum | Cocoa IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99368-3 | Gliadin Ab.IgG | MCnc | Pt | Ser | Qn | null | SERO | 1 | Gliadin IgG Ab [Mass/volume] in Serum | Gliadin IgG Ser-mCnc | null | ACTIVE | 2.72 | 2.72 |
99369-1 | Dactylis glomerata Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Cocksfoot IgG Ab [Mass/volume] in Serum | Cocksfoot IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99370-9 | Tabanus spp Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Horse Fly IgG Ab [Mass/volume] in Serum | Horse Fly IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99371-7 | Culex pipiens Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Culex mosquito IgG Ab [Mass/volume] in Serum | Culex mosquito IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99372-5 | Platanus acerifolia Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | London Plane IgG Ab [Mass/volume] in Serum | London Plane IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99373-3 | Alnus incana Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Grey Alder IgG Ab [Mass/volume] in Serum | Grey Alder IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
9937-4 | Q wave duration.lead AVF | Time | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave duration in lead AVF | Q wave dur L-AVF | null | ACTIVE | 1.0i | 2.48 |
99374-1 | Betula verrucosa Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Silver Birch IgG Ab [Mass/volume] in Serum | Silver Birch IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99375-8 | Corylus avellana pollen Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Hazelnut Pollen IgG Ab [Mass/volume] in Serum | Hazelnut Poln IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99376-6 | Olea europaea pollen Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Olive Pollen IgG Ab [Mass/volume] in Serum | Olive Poln IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99377-4 | Parietaria judaica Ab.IgG | MCnc | Pt | Ser | Qn | null | ALLERGY | 1 | Pellitory (Parietaria judaica) IgG Ab [Mass/volume] in Serum | Pellitory (judaic) IgG-mCnc | null | ACTIVE | 2.72 | 2.72 |
99378-2 | Vasopressin | SCnc | Pt | Urine | Qn | null | CHEM | 1 | Vasopressin [Moles/volume] in Urine | Vasopressin Ur-sCnc | null | ACTIVE | 2.72 | 2.72 |
99379-0 | Mercury | SCnc | Pt | Milk | Qn | null | DRUG/TOX | 1 | Mercury [Moles/volume] in Milk | Mercury Mlk-sCnc | null | ACTIVE | 2.72 | 2.72 |
99380-8 | Mercury | SCnc | Pt | CSF | Qn | null | DRUG/TOX | 1 | Mercury [Moles/volume] in Cerebral spinal fluid | Mercury CSF-sCnc | null | ACTIVE | 2.72 | 2.72 |
99381-6 | Mercury | SCnc | Pt | Dial fld | Qn | null | DRUG/TOX | 1 | Mercury [Moles/volume] in Dialysis fluid | Mercury Dial fld-sCnc | null | ACTIVE | 2.72 | 2.72 |
9938-2 | Q wave duration.lead AVL | Time | Pt | Heart | Qn | EKG | EKG.MEAS | 2 | Q wave duration in lead AVL | Q wave dur L-AVL | null | ACTIVE | 1.0i | 2.48 |